• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-吗啉甲基-四氢-2(1H)-嘧啶酮(DD-13)对小白鼠实验性甲病毒感染的抗病毒作用

Antiviral effect of 1-morpholinomethyl-tetrahydro-2(1H)-pyrimidinone (DD-13) in experimental alphaviral infections in white mice.

作者信息

Karparov A, Galabov A S, Sidzhakova D, Danchev D

出版信息

Arzneimittelforschung. 1985;35(8):1269-75.

PMID:3000394
Abstract

1-Morpholinomethyl-tetrahydro-2(1H)-pyrimidinone (DD-13), a selective inhibitor of the alphaviral reproduction in vitro, manifests a pronounced antiviral activity in experimental infections with Semliki forest virus (SFV) and Sindbis virus in white mice (intraperitoneally inoculated with 10-10 000 LD50). Introduced subcutaneously in mice infected with SFV the compound was effective within the dose range of 4.7-300 mg/kg. The effective dose (ED)50 value of DD-13 is about 18.7 mg/kg and the maximum effect is reached with a 150-300 mg/kg dose. The protection index reached 80% and the mean survival time from approximately 7 days in the placebo group was lengthened to 26 days. This high antiviral effect is distinguished by its high selectivity, the selectivity ratio (LD50/ED50) being 385 (LD50 = 7200 mg/kg) and is manifested in infections with massive viral inocula (100-1000 LD50). The effective treatment schedule was determined: two divided daily doses of 37.5-150 mg/kg, beginning on the 3rd day after infection to the 8th day. After intravenous administration of DD-13 in mice infected with SFV a high protective effect was also observed, which was equal to that of the subcutaneous application, but with doses several times lower: in the 3-40 mg/kg. ED50 is about 3.5 mg/kg and the optimal effective dose is 10-20 mg/kg, i.e. 1/12-1/6 of LD50 (116 mg/kg). The selectivity ratio is about 33. The most effective treatment course is accomplished by a 10-20 mg/kg daily dose (in two applications) starting on the 2nd day after the virus inoculation up to the 8th day.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

1-吗啉甲基-四氢-2(1H)-嘧啶酮(DD-13)是一种体外甲病毒复制的选择性抑制剂,在白色小鼠感染塞姆利基森林病毒(SFV)和辛德毕斯病毒的实验感染中(腹腔注射10 - 10000个半数致死量)表现出显著的抗病毒活性。将该化合物皮下注射到感染SFV的小鼠体内,在4.7 - 300 mg/kg的剂量范围内有效。DD-13的有效剂量(ED)50值约为18.7 mg/kg,在150 - 300 mg/kg剂量时达到最大效果。保护指数达到80%,安慰剂组平均存活时间约7天延长至26天。这种高抗病毒效果以其高选择性为特征,选择性比率(LD50/ED50)为385(LD50 = 7200 mg/kg),并在大量病毒接种(100 - 1000个半数致死量)的感染中表现出来。确定了有效的治疗方案:每日分两次给予37.5 - 150 mg/kg的剂量,从感染后第3天开始至第8天。在感染SFV的小鼠静脉注射DD-13后也观察到高保护效果,与皮下给药相当,但剂量低几倍:3 - 40 mg/kg。ED50约为3.5 mg/kg,最佳有效剂量为10 - 20 mg/kg,即LD50(116 mg/kg)的1/12 - 1/6。选择性比率约为33。最有效的治疗疗程是从病毒接种后第2天开始至第8天,每日给予10 - 20 mg/kg的剂量(分两次给药)。(摘要截取自250字)

相似文献

1
Antiviral effect of 1-morpholinomethyl-tetrahydro-2(1H)-pyrimidinone (DD-13) in experimental alphaviral infections in white mice.1-吗啉甲基-四氢-2(1H)-嘧啶酮(DD-13)对小白鼠实验性甲病毒感染的抗病毒作用
Arzneimittelforschung. 1985;35(8):1269-75.
2
Antiviral activity of tetrahydro-2(1H)-pyrimidinones and related compounds.四氢-2(1H)-嘧啶酮及相关化合物的抗病毒活性。
Arzneimittelforschung. 1984;34(1):9-14. doi: 10.1002/chin.198419231.
3
Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.缺陷干扰病毒对感染致死剂量塞姆利基森林病毒的小鼠的保护作用:病毒增殖的调节
J Gen Virol. 1984 Nov;65 ( Pt 11):1909-20. doi: 10.1099/0022-1317-65-11-1909.
4
The effect of cycloleucine on SFV A7(74) infection in mice.环亮氨酸对小鼠中辛德毕斯病毒A7(74)感染的影响。
Br J Exp Pathol. 1987 Apr;68(2):225-35.
5
Failure of high doses of potentially antiviral agents to prevent death in virus-infected mice.高剂量潜在抗病毒药物未能预防病毒感染小鼠死亡。
Acta Virol. 1985 May;29(3):216-24.
6
Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents.嘧啶酮。1. 2-氨基-5-卤代-6-芳基-4(3H)-嘧啶酮。干扰素诱导抗病毒剂。
J Med Chem. 1985 Dec;28(12):1864-9. doi: 10.1021/jm00150a018.
7
Inhibition by Norakin (triperiden) of Sindbis virus infection in mice.诺拉金(三乙哌苯啶)对小鼠辛德毕斯病毒感染的抑制作用。
Acta Virol. 1985 May;29(3):209-15.
8
Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.单链同聚核苷酸在不诱导干扰素情况下对成年小鼠脑心肌炎病毒和塞姆利基森林病毒的抗病毒活性。
J Gen Virol. 1976 Jan;30(1):21-39. doi: 10.1099/0022-1317-30-1-21.
9
Antiviral activity and mode of action of ribavirin 5'-sulfamate against Semliki Forest virus.利巴韦林5'-氨基磺酸酯对Semliki森林病毒的抗病毒活性及作用模式
Antiviral Res. 1988 Dec 11;10(6):253-62. doi: 10.1016/0166-3542(88)90044-7.
10
Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.缺陷干扰病毒对小鼠全身性Semliki森林病毒感染的调节作用
J Gen Virol. 1984 Oct;65 ( Pt 10):1827-31. doi: 10.1099/0022-1317-65-10-1827.

引用本文的文献

1
Cycluridine: A novel antiviral effective against flaviviruses.环胞苷:一种对黄病毒有效的新型抗病毒药物。
Antivir Chem Chemother. 2017 Aug;25(2):58-67. doi: 10.1177/2040206617723442.
2
Progress of small molecular inhibitors in the development of anti-influenza virus agents.抗流感病毒药物研发中小分子抑制剂的进展
Theranostics. 2017 Feb 8;7(4):826-845. doi: 10.7150/thno.17071. eCollection 2017.